SCHEMBL16694199

SCHEMBL16694199

C1CN(Sc2nc(SN3CCOCC3)nc(SN3CCOCC3)n2)CCO1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 2/20 0.50
ALDH1A1 P00352 4/20 0.44
HSD17B10 Q99714 3/20 0.44
HPGD P15428 2/20 0.44
ALOX15 P16050 2/20 0.44
PKM P14618 2/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 2/20 0.44
HSP90AA1 P07900 1/20 0.35
POLB P06746 1/20 0.34
KMT2A Q03164 2/20 0.34
CXCR4 P61073 1/20 0.33
GAA P10253 1/20 0.32
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
MAPK1 P28482 2/20 0.32
HTT P42858 1/20 0.31
FAAH O00519 1/20 0.31
PHGDH O43175 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28382011 0.78 MGLL (0.39) MGLLALDH1A1HSD17B10HPGDALOX15
SCHEMBL11798954 0.72 MGLL (0.48) MGLLALDH1A1HSD17B10HPGDALOX15
SCHEMBL11851834 0.69 MAPT (0.64) MGLLALDH1A1HSD17B10HPGDALOX15
SCHEMBL4059942 0.67 MGLL (0.65) MGLLALDH1A1HSD17B10HPGDALOX15
Dithiodimorpholine SCHEMBL137538 0.67 MGLL (1.00) MGLLALDH1A1HSD17B10HPGDALOX15
SCHEMBL9579555 0.67 MAPT (0.49) MGLLALDH1A1HSD17B10HPGDALOX15
SCHEMBL28182278 0.66 MGLL (0.37) MGLLALDH1A1HSD17B10HPGDALOX15
SCHEMBL15082071 0.66 LMNA (0.52) MGLLALDH1A1HSD17B10HPGDALOX15
Dithiodimorpholine SCHEMBL29262652 0.65 MGLL (0.93) MGLLALDH1A1PKMMAPTFAAH
Dithiodimorpholine SCHEMBL20769316 0.65 MGLL (0.93) MGLLALDH1A1PKMMAPTFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230072612-A1 FLAME RETARDANT CHEMICAL COMPOSITIONS NORDTREAT FINLAND OY (FI) 2023-03-09 US claimed
EP-4097176-A1 FLAME RETARDANT CHEMICAL COMPOSITIONS Nordtreat Finland OY (FI) 2022-12-07 EP claimed
US-11292968-B2 Sulfenamides as flame retardants SONGWON INTERNATIONAL AG (CH) 2022-04-05 US claimed
CN-110872384-B Flame retardant composition, use thereof and method for the production thereof 松原国际股份有限公司 2022-02-25 CN claimed
WO-2021151493-A1 FLAME RETARDANT CHEMICAL COMPOSITIONS NORDTREAT FINLAND OY (FI) 2021-08-05 WO claimed
EP-3066153-B1 SULFENAMIDES AS FLAME RETARDANTS SONGWON INT AG (CH) 2020-05-06 EP claimed
CN-105829430-B Sulfenamides as flame retardants 松原国际股份有限公司 2019-11-15 CN claimed
US-20160289566-A1 SULFENAMIDES AS FLAME RETARDANTS SONGWON INTERNATIONAL AG (CH) 2016-10-06 US claimed
EP-3066153-A1 SULFENAMIDES AS FLAME RETARDANTS SONGWON INTERNATIONAL AG (CH) 2016-09-14 EP claimed
CN-105829430-A Sulfenamides as flame retardants 松原国际股份有限公司 2016-08-03 CN claimed
WO-2015067736-A1 SULFENAMIDES AS FLAME RETARDANTS WILÉN CARL-ERIC (FI) 2015-05-14 WO claimed
EP-2871208-A1 Sulfenamides, sulfinamides and sulfonamides as flame retardants Wilen, Carl-Eric (FI) 2015-05-13 EP claimed
US-20230072612-A1 FLAME RETARDANT CHEMICAL COMPOSITIONS NORDTREAT FINLAND OY (FI) 2023-03-09 US disclosed
EP-4097176-A1 FLAME RETARDANT CHEMICAL COMPOSITIONS Nordtreat Finland OY (FI) 2022-12-07 EP disclosed
US-11292968-B2 Sulfenamides as flame retardants SONGWON INTERNATIONAL AG (CH) 2022-04-05 US disclosed
CN-110872384-B Flame retardant composition, use thereof and method for the production thereof 松原国际股份有限公司 2022-02-25 CN disclosed
WO-2015067736-A1 SULFENAMIDES AS FLAME RETARDANTS WILÉN CARL-ERIC (FI) 2015-05-14 WO disclosed
WO-2015067736-A1 SULFENAMIDES AS FLAME RETARDANTS WILÉN CARL-ERIC (FI) 2015-05-14 WO disclosed
EP-2871208-A1 Sulfenamides, sulfinamides and sulfonamides as flame retardants Wilen, Carl-Eric (FI) 2015-05-13 EP disclosed
EP-2871208-A1 Sulfenamides, sulfinamides and sulfonamides as flame retardants Wilen, Carl-Eric (FI) 2015-05-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160289566-A1 SULFENAMIDES AS FLAME RETARDANTS STS, TST, PFAS MGLL 2420/4885ALDH1A1 430/4885HSD17B10 590/4885
US-11292968-B2 Sulfenamides as flame retardants STS, TST, PFAS MGLL 2420/4885ALDH1A1 430/4885HSD17B10 590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.